Syncom Formulations (India) Limited (SYNCOMF.NS)

INR 21.04

(-0.14%)

Long Term Debt Summary of Syncom Formulations (India) Limited

  • Syncom Formulations (India) Limited's latest annual long term debt in 2023 was -1.21 Million INR , up 4.47% from previous year.
  • Syncom Formulations (India) Limited's latest quarterly long term debt in 2023 FY was - INR , up 100.0% from previous quarter.
  • Syncom Formulations (India) Limited reported annual long term debt of -1.27 Million INR in 2022, down -16.42% from previous year.
  • Syncom Formulations (India) Limited reported annual long term debt of -1.09 Million INR in 2021, up 37.87% from previous year.
  • Syncom Formulations (India) Limited reported quarterly long term debt of -1.21 Million INR for 2023 Q4, down 0.0% from previous quarter.
  • Syncom Formulations (India) Limited reported quarterly long term debt of - INR for 2023 FY, up 100.0% from previous quarter.

Annual Long Term Debt Chart of Syncom Formulations (India) Limited (2023 - 2006)

Historical Annual Long Term Debt of Syncom Formulations (India) Limited (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 -1.21 Million INR 4.47%
2022 -1.27 Million INR -16.42%
2021 -1.09 Million INR 37.87%
2020 -1.76 Million INR 28.17%
2019 -2.45 Million INR -113.63%
2018 18.02 Million INR 3.65%
2017 17.38 Million INR 2147.45%
2016 -849.31 Thousand INR 0.0%
2015 - INR 0.0%
2014 - INR 0.0%
2013 - INR 0.0%
2012 - INR -100.0%
2011 14.45 Million INR -79.42%
2010 70.2 Million INR -26.12%
2009 95.01 Million INR -11.56%
2008 107.43 Million INR 48.64%
2007 72.28 Million INR 2.68%
2006 70.39 Million INR 0.0%

Peer Long Term Debt Comparison of Syncom Formulations (India) Limited

Name Long Term Debt Long Term Debt Difference
Sigachi Industries Limited 265.79 Million INR 100.459%
Ind-Swift Limited 10.09 Billion INR 100.012%
Bajaj HealthCare Limited 650.34 Million INR 100.187%
Sakar Healthcare Limited 549.55 Million INR 100.222%
Aurobindo Pharma Limited 21.34 Billion INR 100.006%
Innova Captab Limited 2.1 Billion INR 100.058%
Divi's Laboratories Limited 20 Million INR 106.095%
AstraZeneca Pharma India Limited 27.83 Million INR 104.379%
Morepen Laboratories Limited 33.64 Million INR 103.624%
Mankind Pharma Limited 325.81 Million INR 100.374%
Sequent Scientific Limited 1.42 Billion INR 100.085%
Wanbury Limited 820 Million INR 100.149%
Laurus Labs Limited 7.98 Billion INR 100.015%
Nectar Lifesciences Limited 1.4 Billion INR 100.087%
Glenmark Life Sciences Limited 147.61 Million INR 100.826%
Alembic Limited 73.9 Million INR 101.65%
Hikal Limited 4.22 Billion INR 100.029%
Alembic Pharmaceuticals Limited 628.8 Million INR 100.194%
Neuland Laboratories Limited 449.2 Million INR 100.271%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 100.516%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 100.08%
IOL Chemicals and Pharmaceuticals Limited - INR Infinity%
Themis Medicare Limited 267.74 Million INR 100.455%
RPG Life Sciences Limited -30.3 Million INR 95.977%
Zydus Lifesciences Limited 251 Million INR 100.486%
Lupin Limited 1.55 Billion INR 100.079%
Amrutanjan Health Care Limited 13.96 Million INR 108.727%
Wockhardt Limited 8.91 Billion INR 100.014%
Vaishali Pharma Limited 35.98 Million INR 103.388%
Aarti Pharmalabs Limited 400 Thousand INR 404.75%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 101.613%
Jubilant Pharmova Limited 31.67 Billion INR 100.004%
FDC Limited 2.46 Million INR 149.432%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 100.02%
Kilitch Drugs (India) Limited - INR Infinity%
Eris Lifesciences Limited 6.54 Billion INR 100.019%
Venus Remedies Limited 386.8 Million INR 100.315%
ZIM Laboratories Limited 356 Million INR 100.342%
Bliss GVS Pharma Limited 355.92 Million INR 100.342%
Par Drugs and Chemicals Limited - INR Infinity%
Caplin Point Laboratories Limited 9.2 Million INR 113.25%
Shilpa Medicare Limited 5.6 Billion INR 100.022%
Albert David Limited 6.01 Million INR 120.263%
Ajanta Pharma Limited 235.2 Million INR 100.518%
Hester Biosciences Limited 1.81 Billion INR 100.067%
Suven Pharmaceuticals Limited 212.35 Million INR 100.574%
Solara Active Pharma Sciences Limited 1.17 Billion INR 100.104%
Gufic Biosciences Limited 1.53 Billion INR 100.079%
Windlas Biotech Limited 20.18 Million INR 106.041%
Procter & Gamble Health Limited 68.8 Million INR 101.772%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR 103.781%
Mangalam Drugs & Organics Limited 133.54 Million INR 100.913%
Granules India Limited 689.71 Million INR 100.177%
Aarti Drugs Limited 2.75 Billion INR 100.044%
Bal Pharma Limited 363.82 Million INR 100.335%
Alkem Laboratories Limited 400 Million INR 100.305%
Sun Pharmaceutical Industries Limited 13.3 Million INR 109.165%
Lincoln Pharmaceuticals Limited - INR Infinity%
Medicamen Biotech Limited 12.55 Million INR 109.709%
Unichem Laboratories Limited 382.22 Million INR 100.319%
Bafna Pharmaceuticals Limited 107.53 Million INR 101.134%
Biofil Chemicals and Pharmaceuticals Limited - INR Infinity%
Valiant Laboratories Limited 750.89 Million INR 100.162%
Orchid Pharma Limited 1.2 Billion INR 100.101%
Medico Remedies Limited 8.67 Million INR 114.057%
Ind-Swift Laboratories Limited 111.62 Million INR 101.092%
Ipca Laboratories Limited 5.8 Billion INR 100.021%
Brooks Laboratories Limited 3.56 Million INR 134.194%
Piramal Enterprises Limited 535.85 Billion INR 100.0%
Torrent Pharmaceuticals Limited 16.04 Billion INR 100.008%
NATCO Pharma Limited 53 Million INR 102.3%
Suven Life Sciences Limited - INR Infinity%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 100.066%
Strides Pharma Science Limited 6.71 Billion INR 100.018%
Indoco Remedies Limited 3.51 Billion INR 100.035%
Alpa Laboratories Limited - INR Infinity%
Lasa Supergenerics Limited - INR Infinity%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 101.144%